The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age

The quadrivalent human papillomavirus (qHPV) vaccine demonstrated high efficacy against vaccine-type-related precancers in Chinese females through a 6.6-year double-blind, randomized control trial (V501–041, NCT00834106). We present results for its long-term follow-up (LTFU) phase, evaluating vaccin...

Full description

Saved in:
Bibliographic Details
Main Authors: Tianmeng Wen, Xiaoqian Xu, Chenghao Pan, Shangying Hu, Huan Zhao, Xun Zhang, Youlin Qiao, Fanghui Zhao
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Human papillomavirus vaccine
effectiveness
cervical intraepithelial neoplasia
immunogenicity
long-term follow-up
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2412391
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2024.2412391

Similar Items